Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green
Jessica A Carr,Daniel Franke,Justin R Caram,Collin F Perkinson,Mari Saif,Vasileios Askoxylakis,Meenal Datta,Dai Fukumura,Rakesh K Jain,Moungi G Bawendi,Oliver T Bruns,Jessica A. Carr,Justin R. Caram,Collin F. Perkinson,Rakesh K. Jain,Moungi G. Bawendi,Oliver T. Bruns
DOI: https://doi.org/10.1073/pnas.1718917115
IF: 11.1
2018-04-06
Proceedings of the National Academy of Sciences
Abstract:Significance Imaging in the shortwave IR (SWIR) spectral window allows the observation of processes deep within living animals. Recent studies have shown that SWIR imaging enables unprecedented imaging opportunities, including contact-free monitoring of vital signs, generation of microvasculature blood flow maps, real-time metabolic imaging, and molecularly targeted imaging. Yet, whereas bright SWIR fluorophores have been developed for preclinical research settings, applications in the clinic have been held back by the conventional belief that no clinically approved fluorophore is available. Here, we show that indocyanine green, a clinically approved near-IR dye, exhibits a remarkable amount of SWIR emission, which enables state-of-the-art SWIR imaging with direct translation potential into clinical settings, and even outperforms other commercially available SWIR emitters.
multidisciplinary sciences